SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-190246
Filing Date
2015-05-15
Accepted
2015-05-15 16:23:18
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d899106d10q.htm 10-Q 536395
2 EX-31.1 d899106dex311.htm EX-31.1 8665
3 EX-31.2 d899106dex312.htm EX-31.2 8634
4 EX-32.1 d899106dex321.htm EX-32.1 5358
11 GRAPHIC g899106g27q71.jpg GRAPHIC 126655
  Complete submission text file 0001193125-15-190246.txt   3512565

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT sage-20150331.xml EX-101.INS 318046
6 XBRL TAXONOMY EXTENSION SCHEMA sage-20150331.xsd EX-101.SCH 30954
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sage-20150331_cal.xml EX-101.CAL 35253
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sage-20150331_def.xml EX-101.DEF 132636
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sage-20150331_lab.xml EX-101.LAB 292490
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sage-20150331_pre.xml EX-101.PRE 201052
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 15869863
SIC: 2834 Pharmaceutical Preparations